Research Output per year
After having served on the faculty at both Duke and UNC, Dr. Jhaveri joined the faculty at Lurie/FSM in October 2018. He currently serves as Associate Division Head for Pediatric Infectious Diseases. Dr. Jhaveri is active in leadership of several infectious diseases society at the national level. He currently serves as a member of the Pediatric Infectious Diseases Society Board of Directors. He is the Vice-Chair of the Infectious Diseases Society of America Leadership Institute working group and is the PIDS liaison to the IDSA Standards, Practice and Guidelines Committee. He is a member of the AASLD-IDSA HCV Guidelines committee where he serves as one of the subgroup chairs on HCV in Children and Pregnant Women.
Dr. Jhaveri has focused on all aspects of Hepatitis C virus infection. In the past, he ran a laboratory dedicated to study the effect of HCV on lipid metabolism in liver cells and viral and host determinants of HCV vertical transmission. He has been very active in studies of HCV in infants and children: epidemiology, natural history and treatment, testing and advocacy. Dr. Jhaveri's other interests include outcomes studies in pediatric infectious diseases, influenza and the live-attenuated influenza vaccine, prevention, treatment and vertical transmission of Hepatitis B, management of febrile infants and physician decision-making.
Dr. Jhaveri's clinical practice is in all aspects of pediatric infectious diseases. His specialty is in management of children with Hepatitis B & C exposure and infection.
|1999||Residency, University of Chicago Hospitals|
|2003||Fellowship, UCLA Medical Center, Los Angeles, CA|
MD, Mount Sinai School of Medicine
… → 1996
Research output: Contribution to journal › Comment/debate
Cost Effectiveness of Early Treatment with Direct-Acting Antiviral Therapy in Adolescent Patients with Hepatitis C Virus InfectionNguyen, J., Barritt, A. S. & Jhaveri, R. R., Apr 1 2019, In : Journal of Pediatrics. 207, p. 90-96 7 p.
Research output: Contribution to journal › Article
Evaluating Hepatitis B Seroprotection and Revaccination for Children With Inflammatory Bowel DiseaseBrenner, E. J., Jhaveri, R., Kappelman, M. D. & Gulati, A. S., Aug 20 2019, In : Inflammatory bowel diseases. 25, 9, p. e108
Research output: Contribution to journal › Letter
Research output: Contribution to journal › Editorial
Myths and Misconceptions: Varicella-Zoster Virus Exposure, Infection Risks, Complications, and TreatmentsNewman, A. M. & Jhaveri, R., Sep 2019, In : Clinical Therapeutics. 41, 9, p. 1816-1822 7 p.
Research output: Contribution to journal › Review article